Mar 16, 2017 - Jazz Pharmaceuticals plc (JAZZ) recently announced the initiation of patient enrollment in a phase III study evaluating the efficacy and safety of its pipeline candidate, JZP-258, for the potential treatment of adult narcolepsy patients.
May 17, 2017 - New Strong Buy Stocks for May 17th
Mar 10, 2016 - Addus Homecare Corporation (NASDAQ:ADUS) Q4 2015 Earnings Conference Call March 8, 2016 9:00 am ET Executives Dirk Allison - President, Chief Executive Officer Don Klink - Executive Vice President, Ch
Jul 29, 2016 - Here, we take a sneak peek at two healthcare stocks scheduled to report their second-quarter figures on Aug 1.
Aug 02, 2016 - Addus HomeCare Corporation (NASDAQ:ADUS) Q2 2016 Results Earnings Conference Call August 2, 2016 9:00 a.m. ET Executives Dirk Allison - President and Chief Executive Officer Brian Poff - Executive Vic
Mar 22, 2017 - Keryx Biopharmaceuticals, Inc. (KERX) announced that the nation's largest Medicare Part D plan sponsor has added Auryxia (ferric citrate) to its Medicare Part D plan formularies.
Mar 16, 2017 - Catalyst Pharmaceuticals, Inc. (CPRX) reported a loss of 5 cents per share in the fourth quarter of 2016, a penny narrower than the Zacks Consensus Estimate and also narrower than the loss of 7 cents in the year-ago quarter.
Mar 16, 2017 - TrovaGene Inc. (TROV) reported loss of 31 cents per share in the fourth quarter of 2016, 2 cents wider than the Zacks Consensus Estimate.
Mar 23, 2017 - Alexion Pharmaceuticals, Inc. (ALXN) announced that it has submitted an application to Japan's Ministry of Labour and Welfare (MHLW) for the label expansion for Soliris to treat patients with refractory generalized myasthenia gravis (gMG).
Mar 24, 2017 - Roche Holding AG's (RHHBY) member, Genentech announced that the FDA has granted Breakthrough Therapy Designation status to Rituxan (rituximab) for the treatment of pemphigus vulgaris.